Skip to main content
A

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 TW Professional, scientific and technical activities
Filings indexed 1,472 across all filing types
Latest filing 2026-02-25 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
114年度毛利率
Regulatory Filings
2026-02-25 Chinese
公告本公司114年度個體暨合併財務報告提案董事會決議 預計召開日期為115年02月25日
Regulatory Filings
2026-02-13 Chinese
115年1月背書保證與資金貸與
Regulatory Filings
2026-02-10 Chinese
115年1月營業收入
Regulatory Filings
2026-02-10 Chinese
115年01月內部人持股異動(事後)
Regulatory Filings
2026-02-04 Chinese
115年01月董事會成員及持股
Regulatory Filings
2026-02-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.